ProfileGDS4132 / 237360_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 36% 38% 50% 37% 29% 31% 41% 45% 39% 32% 37% 35% 32% 38% 28% 33% 25% 27% 29% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10191.31736
GSM201543Muscle PCOS pioglitazone 12188.629438
GSM201544Muscle PCOS pioglitazone 161134.94350
GSM201545Muscle PCOS pioglitazone 201102.74437
GSM201829Muscle PCOS pioglitazone 23177.185429
GSM201830Muscle PCOS pioglitazon 25179.020831
GSM201831Muscle PCOS pioglitazone 271105.17541
GSM201832Muscle PCOS pioglitazone 31115.96545
GSM201833Muscle PCOS pioglitazone 4195.070639
GSM201834Muscle PCOS pioglitazone 8176.981232
GSM201835Muscle PCOS after pioglitazone 10281.620237
GSM201836Muscle PCOS after pioglitazone 12277.914435
GSM201837Muscle PCOS after pioglitazone 16265.235532
GSM201838Muscle PCOS after pioglitazone 20287.614338
GSM201839Muscle PCOS after pioglitazone 23259.990228
GSM201840Muscle PCOS after pioglitazone 25278.256933
GSM201841Muscle PCOS after pioglitazone 27245.997325
GSM201842Muscle PCOS after pioglitazone 3251.116427
GSM201843Muscle PCOS after pioglitazone 4270.688429
GSM201844Muscle PCOS after pioglitazone 8275.491432